Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)
NCT ID: NCT05811247
Last Updated: 2025-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
660 participants
INTERVENTIONAL
2023-08-28
2025-05-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)
NCT05813275
Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD
NCT06841640
A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT04647383
AD816 Crossover Study
NCT05793684
Study of OsrhAAT or Placebo in Healthy Volunteers
NCT05315921
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AD109
AD109
AD109
Oral administration at bedtime.
Placebo
Placebo
Placebo
Oral administration at bedtime.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AD109
Oral administration at bedtime.
Placebo
Oral administration at bedtime.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. PSG criteria: AHI of \>5; ≤ 25% central or mixed apneas; and PLM arousal index ≤15
3. PROMIS-Fatigue: raw score ≥17
4. PAP intolerance or current PAP refusal.
5. BMI between 18.5 and 40 kg/m2 for men, or 42 kg/m2 for women, inclusive.
Exclusion Criteria
2. Insomnia disorder characterized by difficulty initiating or maintaining sleep, or use within the past month of sedative-hypnotics or other medication for the purpose of treating or avoiding insomnia symptoms.
3. Pierre Robin, Treacher Collins, or other craniofacial malformation syndrome, or grade ≥3 tonsillar hypertrophy.
4. Clinically significant cardiac disease, e.g., ventricular arrhythmia, untreated or unstable coronary artery disease, cardiac failure. Stable atrial arrhythmia is allowed.
5. Neuromuscular disorder (e.g., motor neuron disease, muscular dystrophy or myopathy, myasthenic syndrome); epilepsy; Parkinson, Alzheimer, or other neurodegenerative disease.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Apnimed
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sleep Disorders Center of Alabama
Birmingham, Alabama, United States
Chandler Clinical Trials
Chandler, Arizona, United States
Preferred Research Partners, Inc.
Little Rock, Arkansas, United States
Orange County Research Institute
Anaheim, California, United States
Marvel Clinical Research, LLC
Huntington Beach, California, United States
CenExel CNS
Los Alamitos, California, United States
Santa Monica Clinical Trials
Los Angeles, California, United States
Empire Clinical Research
Pomona, California, United States
Pacific Research Network
San Diego, California, United States
SDS Clinical Trials Inc.
Santa Ana, California, United States
Alpine Clinical Research Center
Boulder, Colorado, United States
Mountain View Clinical Research, Inc.
Denver, Colorado, United States
Nuvance Health
Norwalk, Connecticut, United States
Teradan Clinical trials LLC
Brandon, Florida, United States
St. Francis Medical Institute
Clearwater, Florida, United States
Nouvelle Clinical Research
Cutler Bay, Florida, United States
Arrow Clinical Trials
Daytona Beach, Florida, United States
Cenexel Research Centers of America - Hollywood
Hollywood, Florida, United States
Ivetmar Medical Group LLC
Miami, Florida, United States
PharmaDev Clinical Research Institute, LLC
Miami, Florida, United States
Renstar Medical Research
Ocala, Florida, United States
Palm Beach Research ClinEdge-PPDS
West Palm Beach, Florida, United States
Clinical Site Partners, LLC dba Flourish Research
Winter Park, Florida, United States
NeuroTrials Research
Atlanta, Georgia, United States
CenExel iResearch
Decatur, Georgia, United States
Sleep Practitioners, LLC
Macon, Georgia, United States
Centricity Research Rincon Pulmonology
Rincon, Georgia, United States
Medster Research
Valdosta, Georgia, United States
Chicago Research Center Inc
Chicago, Illinois, United States
Sleep Disorders Centers of the Mid-Atlantic
Glen Burnie, Maryland, United States
Velocity Clinical Research
Rockville, Maryland, United States
Neurocare, Inc
Newton, Massachusetts, United States
Infinity Medical Research
North Dartmouth, Massachusetts, United States
Baystate Medical Center (BMC) - Baystate Sleep Medicine
Springfield, Massachusetts, United States
Western Michigan University Homer Stryker M.D. School of Medicine
Kalamazoo, Michigan, United States
Henry Ford Health (Sleep Research Department)
Novi, Michigan, United States
Clinical Neurophysiology Services
Sterling Heights, Michigan, United States
St Lukes Hospital
Chesterfield, Missouri, United States
Healthcare Research Network
Hazelwood, Missouri, United States
Clayton Sleep Institute
St Louis, Missouri, United States
Great Plains Health
North Platte, Nebraska, United States
Henderson Clinical Trials
Henderson, Nevada, United States
Clinilabs, Inc
Eatontown, New Jersey, United States
Maimonides Sleep Arts and Sciences
Albuquerque, New Mexico, United States
Northwell Health Physician Partners
New Hyde Park, New York, United States
Research Carolina Elite
Denver, North Carolina, United States
Clinical Research of Gastonia
Gastonia, North Carolina, United States
Advanced Respiratory and Sleep Medicine, LLC
Huntersville, North Carolina, United States
Coastal Carolina Health Care
New Bern, North Carolina, United States
Meridian Clinical Research
Raleigh, North Carolina, United States
NeuroScience Research Center, LLC
Canton, Ohio, United States
CTI Clinical Research Center
Cincinnati, Ohio, United States
Sleep Management Institute
Cincinnati, Ohio, United States
Ohio Sleep Medicine Institute
Dublin, Ohio, United States
Northwest Research Center
Portland, Oregon, United States
Brian Abaluck, LLC
Malvern, Pennsylvania, United States
UPMC Comprehensive Lung Center - Sleep Medicine
Pittsburgh, Pennsylvania, United States
Lowcountry Lung and Critical Care
Charleston, South Carolina, United States
Velocity Clinical Research - Greenville
Greenville, South Carolina, United States
Clinical Neuroscience Solutions - Memphis
Memphis, Tennessee, United States
FutureSearch Trials of Neurology
Austin, Texas, United States
Central Texas Neurology Consultants, PA
Round Rock, Texas, United States
Sleep Therapy Research Center
San Antonio, Texas, United States
Sleep Disorders Centers of the Mid-Atlantic
Vienna, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APC-APN-304
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.